131 related articles for article (PubMed ID: 2358378)
1. Ki-67 monoclonal antibody (MAb) reacts with a proliferation associated nuclear antigen in the rabbit Oryctolagus cuniculus.
Apte SS
Histochemistry; 1990; 94(2):201-4. PubMed ID: 2358378
[TBL] [Abstract][Full Text] [Related]
2. Expression of the cell proliferation-associated nuclear antigen reactive with the Ki-67 monoclonal antibody by cells of the skeletal system in humans and other species.
Apte SS
Bone Miner; 1990 Jul; 10(1):37-50. PubMed ID: 2397326
[TBL] [Abstract][Full Text] [Related]
3. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.
van Dierendonck JH; Wijsman JH; Keijzer R; van de Velde CJ; Cornelisse CJ
Am J Pathol; 1991 May; 138(5):1165-72. PubMed ID: 1673821
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary conservation in various mammalian species of the human proliferation-associated epitope recognized by the Ki-67 monoclonal antibody.
Falini B; Flenghi L; Fagioli M; Stein H; Schwarting R; Riccardi C; Manocchio I; Pileri S; Pelicci PG; Lanfrancone L
J Histochem Cytochem; 1989 Oct; 37(10):1471-8. PubMed ID: 2476477
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
[TBL] [Abstract][Full Text] [Related]
7. Determination of proliferative activities in human brain tumor specimens: a comparison of three methods.
Morimura T; Kitz K; Stein H; Budka H
J Neurooncol; 1991 Feb; 10(1):1-11. PubMed ID: 2022970
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrences.
Gaglia P; Bernardi A; Venesio T; Caldarola B; Lauro D; Cappa AP; Calderini P; Liscia DS
Eur J Cancer; 1993; 29A(11):1509-13. PubMed ID: 8217353
[TBL] [Abstract][Full Text] [Related]
9. [Cell cycle analysis using the monoclonal antibody Ki-67].
Isobe H; Shimizu T; Haneda H; Mizuno S; Ishiguro A; Araya Y; Harada M; Miyamoto H; Kawakami Y
Hum Cell; 1988 Jun; 1(2):218-24. PubMed ID: 2979198
[TBL] [Abstract][Full Text] [Related]
10. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.
Swanson SA; Brooks JJ
Am J Pathol; 1990 Dec; 137(6):1491-500. PubMed ID: 1979714
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
Wijsman JH; Van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499
[TBL] [Abstract][Full Text] [Related]
12. Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen?
Holt PR; Moss SF; Kapetanakis AM; Petrotos A; Wang S
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):131-5. PubMed ID: 9037564
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical demonstration of DNA polymerase alpha in human brain-tumor cells.
Kunishio K; Mishima N; Matsuhisa T; Tsuno K; Matsumi N; Satoh T; Matsumoto K; Furuta T; Nishimoto A; Shiraishi T
J Neurosurg; 1990 Feb; 72(2):268-72. PubMed ID: 1967302
[TBL] [Abstract][Full Text] [Related]
14. Detection of the Ki-67 proliferation associated nuclear epitope in normal canine tissues using the monoclonal antibody MIB-1.
Laprie C; Abadie J; Amardeilh MF; Raymond I; Delverdier M
Anat Histol Embryol; 1998 Aug; 27(4):251-6. PubMed ID: 9741148
[TBL] [Abstract][Full Text] [Related]
15. Immunobiochemical characterization of the antigen detected by monoclonal antibody IND.64. Evidence that IND.64 reacts with the cell proliferation associated nuclear antigen previously defined by Ki-67.
Key G; Meggetto F; Becker MH; al Saati T; Schlüter C; Duchrow M; Delsol G; Gerdes J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(4):259-62. PubMed ID: 1279888
[TBL] [Abstract][Full Text] [Related]
16. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.
Key G; Becker MH; Baron B; Duchrow M; Schlüter C; Flad HD; Gerdes J
Lab Invest; 1993 Jun; 68(6):629-36. PubMed ID: 7685843
[TBL] [Abstract][Full Text] [Related]
17. Validation of bromodeoxyuridine immunohistochemistry for localization of S-phase cells in decalcified tissues. A comparative study with tritiated thymidine autoradiography.
Apte SS
Histochem J; 1990 Aug; 22(8):401-8. PubMed ID: 2228729
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67.
Parkins CS; Bush C; Price P; Steel GG
Cell Prolif; 1991 Mar; 24(2):171-9. PubMed ID: 2009320
[TBL] [Abstract][Full Text] [Related]
19. [Expression of a proliferation associated-nuclear antigen defined by Ki-67 monoclonal antibody in childhood acute leukemia].
Ito M; Tsurusawa M; Kawai S; Fujimoto T
Rinsho Ketsueki; 1995 Aug; 36(8):713-9. PubMed ID: 7563603
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies.
Falini B; Canino S; Sacchi S; Ciani C; Martelli MF; Gerdes J; Stein H; Pileri S; Gobbi M; Fagioli M
Br J Haematol; 1988 Jul; 69(3):311-20. PubMed ID: 3165668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
